Moderna Inc (MRNA_KZ)

KASE
Currency in USD
Disclaimer
155.75
0.00
(0.00%)
Delayed Data
Day's Range
155.75
155.75
52 wk Range
120.10
203.07
Volume
0
Bid/Ask
155.75 / 0.00
Prev. Close
155.75
Open
155.75
Day's Range
155.75-155.75
52 wk Range
120.1-203.07
Volume
0
Average Volume (3m)
2
1-Year Change
7.41%
Shares Outstanding
381,209,341
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
218.80
Upside +70.25%

People Also Watch

31.13
INTC
-0.99%
27.78
BAC
+0.76%
207.52
TSLA
+1.76%
226.50
V
+2.47%
63.05
PYPL
+1.71%

Moderna Inc News

Moderna Inc Analysis

Moderna Inc Company Profile

Moderna, Inc. is a biotechnology company. The Company is focused on developing messenger ribonucleic acid (mRNA) therapeutics and vaccines. It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range spectrum of diseases. The Company's products include Spikevax, the Moderna COVID-19 vaccine (mRNA-1273), a bivalent vaccine targeting the BA.1 Omicron variant, combined with Spikevax (mRNA-1273.214), and bivalent vaccine targeting the BA.4/BA.5 Omicron variants combined with Spikevax (mRNA-1273.222). It has a development pipeline of 45 development candidates across its 48 development programs, of which 38 are in clinical studies.